Duhao Net helps individual entrepreneurs and enterprises find high-quality suppliers, reduce procurement costs, and make transactions easier.
Release time:2024-11-15 15:51:45 Source:DuHao
Contact Us Today
Tel : +86 400-623-8666 | 021-50706066
Email: net.fei@163.com
Address: No. 169 Chugong Road, Fengxian District, Shanghai, China
Shanghai Macklin Biochemical Co., Ltd., known as "Macklin Reagent," is a technology enterprise established in December 2013 and located in Zhangjiang, Pudong, Shanghai. The company specializes in the production and R&D of biochemical reagents, covering four major sectors: fine chemistry, life sciences, analytical chromatography, and materials science.
Macklin Reagent's product portfolio is extensive, including universal reagents, drug synthesis reagents, chiral compounds, catalysts and ligands, and analytical reagents. Specific products like antibiotic sensitivity test disks and N. O-Bis(trimethylsilyl) trifluoroacetamide (BSTFA) are used for detecting bacterial resistance to antibiotics and as a derivatization reagent in gas chromatography (GC) analysis, respectively.
Macklin actively engages in exhibitions like the China International SME Expo to showcase its R&D capabilities and product advantages. The company also regularly introduces new products and technical articles, such as the chemical mechanisms of PEG linkers and principles of heterogeneous catalytic reactions, to offer more technical support to customers.
Founded in 2013, Macklin operates integrated supply chain bases in Shanghai and Shandong, covering R&D, production, warehousing, and logistics. The Shanghai facility spans over 10,000 square meters, and the Shandong facility covers 50,000 square meters, with additional warehousing in Guangdong, Chongqing, and Hebei. This strategy enables nationwide "same-day" and "next-day" delivery services.
Macklin places R&D innovation at its core, with chemical and biological labs in Shanghai and pilot labs and plants in Shandong. Led by a world-class expert team, the company introduces tens of new compounds annually through product development, process innovation, and formula enhancements. Macklin holds 73 patents, qualifying it as a national high-tech enterprise, specialized and innovative "Little Giant" enterprise, and a Shanghai scientific and technological "Little Giant" enterprise.
Quality is paramount at Macklin, supported by leading global detection equipment and standards that exceed industry norms, ensuring high-quality, reliable products. The company's website offers 180,000 products, including 60,000 in stock, with a reserve of 5 million bottles across various categories.
Macklin collaborates with numerous top domestic and international research institutions, serving over 200,000 customers. Guided by the ethos of "integrity, customer trust, and mutual benefit," Macklin strives to advance global scientific modernization and foster human technological prosperity through nutritional supplements and catalysts.
In 2022, Macklin completed hundreds of millions of yuan in Pre-IPO round financing, led exclusively by Jingwei Venture Capital. This funding will mainly be used for future factory planning and construction, technological innovation and R&D investment, as well as customer service improvement, to meet the company's rapid development needs and deepen the integration of industry university research applications
Macklin is committed to providing systematic product resources and supporting technical services to global technology and industrial clients, aiming to serve the global scientific technological modernization and contribute to the flourishing of human science and technology.